MedPath

Treatment of ringworm infections of skin with terbinafine

Phase 3
Conditions
Health Condition 1: null- Tinea corporis, tinea cruris, tinea manuum, tinea pedis
Registration Number
CTRI/2017/05/008687
Lead Sponsor
Institute of Medical Sciences Banaras Hindu University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Closed to Recruitment of Participants
Sex
Not specified
Target Recruitment
500
Inclusion Criteria

Patients with tinea corporis, tinea cruris, tinea manuum and tinea pedis who show fungal elements on KOH microscopy of skin scrapings

Exclusion Criteria

1. Use of terbinafine (oral or topical) in past 1 week

2. Pregnancy or lactation

3. Past history of drug reaction to terbinafine (oral or topical)

4. Concurrent hepatic or renal disease as stated by the patient

5. Inability of the patient to come for follow up

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath